Letter to the Editor: Glioma grade

Restricted access

If the inline PDF is not rendering correctly, you can download the PDF file here.

Article Information

Please include this information when citing this paper: published online March 22, 2013; DOI: 10.3171/2012.11.JNS122115.

© AANS, except where prohibited by US copyright law.

Headings

References

  • 1

    Chang CShi YWang CWang JGeng NJiang X: Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma. Neurosci Lett 531:2042082012

  • 2

    Chu SHMa YBFeng DFZhang HZhu ZALi ZQ: Upregulation of SATB1 is associated with the development and progression of glioma. J Transl Med 10:1492012

  • 3

    Lu JKsendzovsky AYang CMehta GUYong RLWeil RJ: CNTF receptor subunit α as a marker for glioma tumor-initiating cells and tumor grade. Laboratory investigation. J Neurosurg 117:102210312012

  • 4

    Towner RAJensen RLColman HVaillant BSmith NCasteel R: ELTD1, a potential new biomarker for gliomas. Neurosurgery 72:77912013

  • 5

    Turtoi AMusmeci DNaccarato AGScatena COrtenzi VKiss R: Sparc-like protein 1 is a new marker of human glioma progression. J Proteome Res 11:501150212012

  • 6

    Wang LYuan JTu YMao XHe SFu G: Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma. Clin Transl Oncol 15:1391452013

  • 7

    Wang QWang LLi DDeng JZhao ZHe S: Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients. Cancer Epidemiol 37:79842013

  • 1

    Chen JLi YYu TSMcKay RMBurns DKKernie SG: A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488:5225262012

  • 2

    Lu JKovach JSJohnson FChiang JHodes RLonser R: Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms. Proc Natl Acad Sci U S A 106:11697117022009. (Erratum in Proc Natl Acad Sci U S A 106:14734 2009)

  • 3

    Sanai NAlvarez-Buylla ABerger MS: Neural stem cells and the origin of gliomas. N Engl J Med 353:8118222005

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 84 84 18
Full Text Views 74 74 2
PDF Downloads 29 29 0
EPUB Downloads 0 0 0

PubMed

Google Scholar